TAIHUSNOW CO.,LTD.
838262
Guangdong Brandmax Marketing
300805
Guangdong Transtek Medical Electronics
300562
Suzhou Kingswood Education Technology
300192
Broadex Technologies
300548
CN Stock MarketDetailed Quotes
002773 Chengdu Kanghong Pharmaceutical Group
- 19.85
- -0.14-0.70%
Market Closed Dec 16 15:00 CST
18.26BMarket Cap15.30P/E (TTM)
20.09High19.73Low51.77KlotVolume20.00Open19.99Pre Close102.90MTurnover0.76%Turnover Ratio17.47P/E (Static)919.78MShares24.5052wk High2.16P/B13.60BFloat Cap12.7752wk Low21.99Limit Up685.34MShs Float52.71Historical High17.99Limit Down1.80%Amplitude6.72Historical Low0.38Dividend TTM19.88Avg Price28.40KlotAsk1.91%Div YieldTTM100Lot Size21.18KlotBid
Chengdu Kanghong Pharmaceutical Group News
Kanghong Pharmaceutical: Announcement on Cancelling Some Special Fund Raising Accounts
Kanghong Pharmaceutical: Announcement of Supervisory Committee Resolutions
Kanghong Pharmaceutical: Announcement of Board Resolutions
Kanghong Pharmaceutical: Investor Relations Activity Record Form for September 12, 2024
Kanghong Pharmaceutical: Announcement on participating in the 2024 Investor Online Group Reception Day and Semi-Annual Report Performance Briefing in the Sichuan Region
Chengdu Kanghong Pharmaceutical Group: Announcement of Board of Directors' resolution for semi-annual report.
Chengdu Kanghong Pharmaceutical Group: Special report on the use and placement of funds raised during the first half of 2024.
Chengdu Kanghong Pharmaceutical Group: Announcement of the resolution of the Supervisory Board on the semi-annual report.
Chengdu Kanghong Pharmaceutical Group: Announcement of Resolutions of the 7th Meeting of the Eighth Board of Supervisors
Chengdu Kanghong Pharmaceutical Group: Announcement of Resolutions of the 7th Meeting of the 8th Board of Directors
Chengdu Kanghong Pharmaceutical Group: May 8, 2024 Investor Relations Activity Record
Kanghong Pharmaceutical: Announcement on holding the 2023 results briefing
Kanghong Pharmaceutical: 2023 Independent Director Debriefing Report (Zhang Yu)
Kanghong Pharmaceutical: 2023 Independent Director Debriefing Report (Deng Hongguang)
Kanghong Pharmaceutical: Report on the work of the Supervisory Committee in 2023
Kanghong Pharmaceutical: Announcement on renewing the employment of an accounting firm
Kanghong Pharmaceutical: Internal Control Audit Report
Kanghong Pharmaceutical: Announcement of Board Resolutions
Kanghong Pharmaceutical: Special opinion of the board of directors on the evaluation of the independence of independent directors
Kanghong Pharmaceutical: 2023 Independent Director Debriefing Report (Zhou Demin)
